title: What do we know about the cardiac benefits of exercise?
abstract: Exercise has long been considered an essential element for sustaining cardiovascular health. A vast literature of clinical studies suggests that exercise serves as an effective intervention for the primary and secondary prevention of cardiovascular disease, although the optimal nature, intensity, and duration of exercise for maximizing these cardiovascular benefits remain unclear. On a molecular level, exercise induces physiologic growth of the heart primarily by driving cardiomyocyte hypertrophy, notably through the interconnected IGF-1-PI3K-AKT1 and C/EBPβ-CITED4 pathways. Here, we explore the range of clinical evidence supporting the cardiovascular benefits of exercise and outline the molecular pathways that play major roles in regulating these protective effects.
authors: Cardiovascular Division, Beth Israel Deaconess Medical Center, Center for Life Sciences, Harvard Medical School, Boston, MA.
authors: Xin
authors: X
authors: Wei
authors: Cardiovascular Division, Beth Israel Deaconess Medical Center, Center for Life Sciences, Harvard Medical School, Boston, MA.
authors: Xiaojun
authors: X
authors: Liu
authors: Cardiovascular Division, Beth Israel Deaconess Medical Center, Center for Life Sciences, Harvard Medical School, Boston, MA. Electronic address: arosenzweig@partners.org.
authors: Anthony
authors: A
authors: Rosenzweig
mesh_terms: D002318:Cardiovascular Diseases / Q000517:prevention & control*; D015444:Exercise / Q000502:physiology*; D005260:Female; D006801:Humans; D008297:Male; D008967:Molecular Biology; D032383:Myocytes, Cardiac / Q000378:metabolism; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism*; D010809:Physical Fitness / Q000502:physiology; D011379:Prognosis; D015398:Signal Transduction; D020257:Ventricular Remodeling / Q000502:physiology*
chemical_list: D019869:Phosphatidylinositol 3-Kinases